Morbidity and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Data from the DGAV StuDoQ Registry with 2149 Consecutive Patients
- 19 November 2018
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 26 (1) , 148-154
Abstract
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are performed for well-selected patients with peritoneal surface malignancies. This combined treatment is...Keywords
This publication has 22 references indexed in Scilit:
- Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgery, 2012
- Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and BasicsCancer Investigation, 2012
- Missing Data and Interpretation of Cancer Surgery Outcomes at the American College of Surgeons National Surgical Quality Improvement ProgramJournal of the American College of Surgeons, 2011
- Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignanciesJournal of Surgical Oncology, 2009
- Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?Annals of Surgery, 2009
- Safety of Gastric Resections During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal CarcinomatosisAnnals of Surgical Oncology, 2009
- Morbidity and Mortality With Cytoreductive Surgery and Intraperitoneal ChemotherapyThe Cancer Journal, 2009
- Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 proceduresEuropean Journal of Surgical Oncology, 2006
- Cytoreductive surgery followed by intraperitoneal hyperthermic perfusionCancer, 2006
- Peritonectomy ProceduresAnnals of Surgery, 1995